MAP
KRTX

Moody Aldrich Partners’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Moody Aldrich Partners’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,951
Closed -$934K – 244
2023
Q4 		$934K Buy
2,951
+739
+33% +$144K 0.17% 118
2023
Q3 		$374K Sell
2,212
-7,215
-77% -$1.36M 0.07% 147
2023
Q2 		$2.04M Sell
9,427
-3,480
-27% -$746K 0.4% 93
2023
Q1 		$2.34M Sell
12,907
-5,148
-29% -$985K 0.47% 82
2022
Q4 		$3.55M Buy
18,055
+2,816
+18% +$604K 0.72% 61
2022
Q3 		$3.43M Sell
15,239
-4,681
-23% -$947K 0.71% 62
2022
Q2 		$2.52M Buy
+19,920
New +$2.29M 0.5% 76
2021
Q2 		– Sell
-9,929
Closed -$1.19M – 203
2021
Q1 		$1.19M Sell
9,929
-9,478
-49% -$1.07M 0.17% 111
2020
Q4 		$1.97M Sell
19,407
-11,563
-37% -$1.07M 0.32% 92
2020
Q3 		$2.4M Buy
30,970
+672
+2% +$57.3K 0.5% 83
2020
Q2 		$3.38M Buy
30,298
+4,454
+17% +$387K 0.72% 61
2020
Q1 		$1.86M Buy
25,844
+40
+0.2% +$3.42K 0.56% 70
2019
Q4 		$1.94M Buy
+25,804
New +$1.13M 0.4% 89

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Moody Aldrich Partners's KRTX Position: Q1 2024 in Review

Moody Aldrich Partners sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,951 shares — an estimated $934K sold.

Moody Aldrich Partners first reported a position in KRTX in Q4 2019 and held it in 13 quarters. The position peaked at $3.55M in Q4 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Moody Aldrich Partners reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 2,951 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $934K.
  • Moody Aldrich Partners first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 13 quarters.
  • Moody Aldrich Partners's Karuna Therapeutics, Inc. Common Stock position peaked at $3.55M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Moody Aldrich Partners's 13F filing for Q1 2024, filed 30 Apr 2024.